The companies have agreed to share information with ICE about vendors selling medical supplies that they deem suspect. They will work together to identify suspicious shipments and take down suspicious online listings for medical supplies related to COVID-19.
“This information-sharing effort allows the government to then make more informed decisions about targeting suspicious international shipments,” Lev Kubiak, chief security officer for Pfizer, told the Journal.
The partnership also includes Merck, Citigroup and Alibaba Group.
U.S. officials said they anticipate a surge of counterfeit or subpar imported goods, and they have found a significant number of imported face masks don’t meet certification standards, according to the Journal.
“It poses a serious health concern to the American public when they are wearing face masks that they think have the protection of N95 masks but are really substandard,” Steve Francis, director of ICE’s National Intellectual Property Rights Coordination Center told the Journal.
So far, Customs and Border Protection has seized about 500 shipments of unauthorized products, including protective equipment and fake COVID-19 tests.
Read the full article here.
More articles on supply chain:
COVID-19 testing update: Where the US stands now
LabCorp offering free antibody tests for anyone with provider order
Kaiser building $14M COVID-19 testing facility
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
